By David P. Meyer, Esq. and Courtney Werning, Esq. David P. Meyer is the founder and managing principal of Meyer Wilson Werning, past president of the Public Investors Advocate Bar Association (PIABA), and author of the Amazon #1 best-seller The Investor Protector: Stories of Triumph Over Financial Advisors Who Lie, Cheat, and Steal. Courtney Werning is a principal at the firm, currently serves as Vice-President of PIABA, and has been quoted in The Wall Street Journal and Bloomberg, among many other journals. Together they have helped recover more than $350 million for investors and consumers.
Last reviewed:09/2026. Request a free case review. See our past matters and results.
Investigations open right now: Forge Global / Sestante Capital pre-IPO fraud | Comenity Capital Bank prerecorded “tax” robocalls (TCPA) | Rideshare sexual assault (Uber / Lyft) | GLP-1 drug injuries (Ozempic, Wegovy, Mounjaro, Zepbound) | Suboxone film dental injuries | Daniel Merithew Allen / 99 Acquisition Group selling away (UBS) | Luong Pham / EHang overconcentration (Axim Planning & Wealth)
If your experience matches one of these, or if you were harmed by conduct we have not listed yet, we want to hear from you. Every review is free and confidential, and you owe nothing unless we recover for you.
Meyer Wilson Werning opens investigations into brokers, firms, funds, and companies whose conduct may have harmed investors or consumers. Our practice centers on securities and investment fraud, and, as a firm recognized by U.S. News as a Tier 1 practice for Mass Tort Litigation / Class Actions, Plaintiffs, we also pursue consumer-protection matters through class and mass actions.
How Our Investigations Work
An investigation is how a case often begins. We gather public records, talk with affected people, and assess whether there is a viable claim before anyone commits to anything. Since 1999 we have recovered over $350 million for our clients, and many of those recoveries started exactly this way.
An investigation is not a lawsuit, and being named here does not mean a company has been found liable for anything. It means we are looking closely at a pattern of conduct and evaluating potential claims.
Coming forward early matters for two reasons. First, the people who contact us often supply the very evidence that shapes a case, from account statements to saved voicemails, as examples. Second, many legal deadlines are unforgiving, and waiting can quietly cost you the right to recover. When you reach out, we listen, we explain whether you appear to have a claim, and if you do, we handle all of our cases on a contingency fee basis.
We Are The firm other lawyers
call for support.
Current Investigations
Forge Global and Sestante Capital Pre-IPO Losses
We are investigating whether investors were steered into a fraudulent pre-IPO fund through brokers at Forge Securities LLC. Federal prosecutors have charged the manager of Sestante Capital and its NextGenTech fund with running a scheme built on fabricated access to shares of a well-known private company, and investors who paid in allegedly received nothing.
A registered broker who recommends an investment has a duty to investigate it under Regulation Best Interest and FINRA suitability and supervision rules, not simply accept a fund manager’s claims. That duty is the heart of what we are examining.
You may have a claim if:
- A Forge Global or Forge Securities broker introduced you to Sestante Capital or the NextGenTech funds.
- You were promised exposure to pre-IPO shares in a private technology company and cannot access or redeem your investment.
- You received documents that now appear to have been fabricated.
Read the full details of the Forge Global / Sestante investigation.
Comenity Capital Bank Prerecorded-Call Investigation
We are investigating allegations that Comenity Capital Bank, the credit-card arm of Bread Financial, left prerecorded so-called “tax services” and “tax season” voicemails on consumer cell phones in apparent violation of the federal Telephone Consumer Protection Act (TCPA). Our focus is on people who never opened a Comenity, Bread Financial, or store-branded card account and never consented to the calls.
Under the TCPA, consumers may be entitled to $500 to $1,500 for each illegal call, and if you saved a voicemail, that audio is some of the strongest evidence there is.
You may have a claim if:
- You received one or more prerecorded voicemails you believe came from Comenity Capital Bank.
- The message referenced tax services, a tax refund, or a similar script, and you never owned a Comenity store-branded card.
- You never gave Comenity prior express consent to call your cell phone, or the calls continued after you asked them to stop.
Read the full details of the Comenity Capital Bank investigation.
Rideshare Sexual Assault Litigation (Uber and Lyft)
We are helping lead the federal civil cases against Uber, and our attorney, Layne Hilton, sits on the Plaintiffs’ Steering Committee overseeing it. The claims are brought by passengers who were sexually assaulted by drivers on platforms that built their brands on being the safe way home.
Federal cases are consolidated as MDL No. 3084, In re: Uber Technologies, Inc., Passenger Sexual Assault Litigation, before Judge Charles R. Breyer in the Northern District of California. Created in October 2023, it has grown to nearly 4,000 pending cases as of mid-2026, making it one of the largest active mass torts in the country. More than 500 California cases are coordinated separately in state court, and litigation against Lyft is proceeding on its own track.Â
Internal Uber records unsealed through this litigation show the company logged 400,181 reports of sexual assault or misconduct in the United States between 2017 and 2022, roughly one every eight minutes. Uber sorts incidents into 21 internal categories and publicly reports only the five most severe. The gap between what the company knew and what it disclosed is the heart of these lawsuits.
Two federal bellwether trials have now been tried, and Uber lost both. Judge Breyer has also ruled that Uber can be treated as a common carrier, the same legal category as a taxi service or an airline, which carries a heightened duty of care that cannot be delegated to a contractor.
You may have a claim if:
- A rideshare driver raped, groped, kissed, exposed themself to, or otherwise sexually assaulted you during or in connection with a ride, including conduct that never involved touching.
- The ride was booked through the Uber or Lyft app. This is the one requirement that cannot be worked around, and a trip record, receipt, or account history is what establishes it.
- You never reported the assault to police or to the company. Neither is required, and many survivors did neither.
Claims are also available to drivers who were assaulted by passengers. You are not required to have all the answers before you call, and you can share as much or as little as you are ready to share.
Read the full details of the rideshare sexual assault litigation.
Suboxone Film Dental Injury Litigation
We are helping lead this litigation as well. MWW Attorney Layne Hilton serves on the Plaintiffs’ Executive Committee in MDL No. 3092, the court-appointed body that sets strategy for the entire case. The claims are brought by patients who took sublingual buprenorphine film exactly as prescribed, often for years, and lost their teeth to it.
In January 2022, the FDA warned that buprenorphine medicines dissolved in the mouth could cause severe tooth decay, cavities, oral infections, and tooth loss, having identified 305 reported cases. The agency emphasized that these problems occurred in patients with no prior history of dental trouble. Indivior did not update the Suboxone label until June 2022, a decade after published case reports first linked the formulation to severe decay.
There is something urgent for anyone considering a claim. The court requires plaintiffs to produce records proving both product use and injury, and cases are being dismissed for failing to meet that obligation, in some instances because pharmacies and third-party custodians have refused to produce records at all. Gathering your own records now is the most useful thing you can do.
You may have a claim if:
- You used Suboxone film or another dissolvable buprenorphine product and developed severe decay, tooth loss, extractions, oral infections, gum disease, or jawbone loss.
- Your dental health was reasonably good before treatment began, which is what separates these injuries from the dental problems common in people who used opioids.
- Your use began before the June 2022 label change, when no warning existed at all. Later use can still support a claim depending on what you were told.
Do not stop taking Suboxone because of this page. Stopping medication for opioid use disorder carries a serious risk of relapse and overdose, and no claim is worth that. Any change belongs to you and your prescriber.
Read the full details of the Suboxone dental injury litigation.
GLP-1 Drug Injury Investigation (Ozempic, Wegovy, Mounjaro, Zepbound)
We are evaluating claims for patients who took a GLP-1 medication and were later diagnosed with gastroparesis, ileus or bowel obstruction, gallbladder disease, or NAION, a sudden loss of blood flow to the optic nerve that usually causes permanent vision loss in one eye. The claim is not that these drugs should never have been sold. It is that Novo Nordisk and Eli Lilly understood these risks and did not put adequate warnings in front of patients and the physicians prescribing to them.
There are two federal proceedings here, not one, and they are on very different timelines. The gastrointestinal cases are consolidated in MDL No. 3094, where expert discovery is complete and bellwether selection is the next major step. The vision loss cases are in MDL No. 3163, created in December 2025 and still in early procedural stages. Neither has produced a trial, a verdict, or a settlement, and any site quoting a GLP-1 settlement figure is inventing it.
One requirement decides a large share of stomach injury claims before they start. Judge Marston requires objective diagnostic testing, which in practice means a gastric emptying study. A clinical impression, a chart note, or a diagnosis code entered without testing will generally not be enough on its own.
You may have a claim if:
- You took Ozempic, Wegovy, Rybelsus, Mounjaro, or Zepbound and were later diagnosed with gastroparesis, ileus or intestinal obstruction, or gallbladder disease requiring treatment or removal.
- You experienced sudden painless vision loss in one eye and were diagnosed with NAION.
- Your condition persisted, required significant medical intervention, or did not resolve when the drug was stopped. Ordinary nausea, vomiting, or constipation is not the basis of a claim.
If you are currently taking a GLP-1 medication, do not stop based on anything on this page. That is a conversation for the physician who prescribed it. Whether your records support a claim is a separate question, and a free review will answer it.
Read the full details of the GLP-1 drug injury investigation.
Luong Pham and EHang Holdings Overconcentration Investigation
We are investigating whether clients of Luong Pham (CRD# 2830422) were harmed by overconcentration in a single speculative stock and by an undisclosed business relationship with the company behind it. Pham served as Managing Member and Investment Adviser Representative of Axim Planning & Wealth in Springboro, Ohio. According to SEC 13F filings, the firm’s single largest disclosed holding was EHang Holdings Limited (Nasdaq: EH), 4,398,242 shares valued at roughly $76.4 million, a dominant position in a firm of that size.
During the same period, official EHang press releases and investor relations materials identified Pham as Founder and CEO of Aerial Sea Ventures, an EHang commercial partner in Southeast Asia. He appeared at EHang launch events in Bangkok alongside the company’s CFO and Thai aviation officials, spoke on an eVTOL investment panel in Shanghai, and was featured in an interview published on EHang’s own channels.
The exposure came due in 2026. EHang reported first-quarter revenue of $3.7 million against analyst expectations of $53.9 million, shares fell 23 percent in a single session, and JPMorgan cut its price target from $9.70 to $4.40. Concentrated holders absorbed the full force of that decline.
A registered investment adviser owes a fiduciary duty that includes diversifying client portfolios appropriately and disclosing material conflicts of interest. An outside role as an officer of a company in which an adviser has also concentrated client assets is, by any reasonable standard, material. Pham’s record also includes a 2023 customer dispute alleging unsuitable recommendations at Cetera Advisors, settled for $25,000, where the underlying arbitration claim described over-concentration in risky Chinese stocks. He is no longer registered as a broker or investment adviser.
You may have a claim if:
- Luong Pham or Axim Planning & Wealth managed your accounts and placed a substantial portion of your portfolio in EHang stock.
- You were never told that your adviser served as Founder and CEO of an EHang commercial partner.
- You held EHang or other concentrated Chinese equity positions through Pham at Axim or at a prior firm, including Cetera Advisors, and suffered losses.
Read the full details of the Luong Pham / EHang investigation.
Daniel Merithew Allen and 99 Acquisition Group Selling-Away Investigation
We are investigating allegations that Daniel Merithew Allen, a registered representative associated with UBS Financial Services in Palm Beach Gardens, Florida (CRD#: 2981060), recommended that clients invest in 99 Acquisition Group, an outside entity connected to CEO Hiren Patel, that was not approved for sale by his firm. Investors who have contacted us describe money placed entirely outside their official UBS accounts, which raises the possibility of a practice known as “selling away.”
Selling away happens when a broker solicits an investment that has not gone through the firm’s due diligence and is not held or supervised on the firm’s books. When that occurs, the brokerage firm may be responsible. Under FINRA Rules 3270 and 3280, a firm has an affirmative duty to supervise the outside business activities of its representatives, and a failure to detect and stop selling away can give harmed investors a direct path to recovery through FINRA arbitration.
You may have a claim if:
- Daniel Merithew Allen, or another UBS representative, recommended that you invest in 99 Acquisition Group and it was unsuitable to your portfolio.
- Your money was placed outside your official UBS brokerage account, and the investment does not appear on your firm statements.
- You received private placement memoranda, subscription agreements, or updates from 99 Acquisition Group and can no longer access or redeem your investment.
Read the full details of the Daniel Allen / 99 Acquisition Group investigation.
Our View: Where These Failures Actually Start
It is easy to read stories like the Sestante or 99 Acquisition Group matter as the work of one bad actor and stop there. In our experience across more than two decades of these cases, that framing is usually wrong, and it lets the wrong parties off the hook.
The recurring failure is rarely a single rogue broker. It is a supervision system at the brokerage or branch level that had every tool it needed to catch the problem and did not use it. Regulation Best Interest and FINRA’s supervision rules put an affirmative obligation on the firm, not just the individual, to vet what is sold and to monitor how it is sold. When a fabricated pre-IPO fund reaches a customer’s account, the more important question is often not “why did this broker recommend it?” but “why did the firm’s supervisory framework let it through?” That is where meaningful accountability, and for defrauded investors meaningful recovery, usually lives.
We Have Recovered Over
$350 Million for Our Clients Nationwide.
What to Do If You Think You Are Affected
Whether your concern is an investment loss or an illegal robocall, the same first steps protect your rights:
- Preserve everything, including account statements, emails, text messages, and any saved voicemails.
- Write down a timeline while it is fresh.
- Do not send more money to anyone promising to “unlock” a return.
- Talk to us before a deadline passes.
Our lawyers are nationwide leaders in investment fraud cases.
Why Investors and Consumers Choose Meyer Wilson Werning
- We have recovered over $350 million for our clients and hold more than 75 years’ of combined experience across securities and consumer-protection matters.
- Our attorneys have served as court-appointed class counsel and secured landmark results, and they are recognized leaders in investor and consumer advocacy.
- Every matter is handled on a contingency fee basis, so there is no cost to come forward.
- Most of all, our clients speak for us, and you can read what they say about working with our team.
Contact Us About an Active Investigation
If any investigation on this page matches your experience, or if you believe you were harmed by conduct we have not listed yet, contact Meyer Wilson Werning for a free, confidential review. The sooner we hear from you, the more we can do to protect your claim, and you owe nothing unless we recover for you.
Meyer Wilson Werning. Call 844-410-9143. Request a free case review. Offices in Ohio, California, Michigan, and Louisiana. Representing investors and consumers nationwide.
The information on this page is based on public sources, including news outlets and federal, state, and regulatory filings, except where marked as the firm’s own internal data. All individuals and entities are presumed innocent unless and until proven otherwise in a court of law or administrative proceeding, and all allegations are allegations only until a court or regulatory agency finds otherwise.
Recovering Losses Caused by Investment Misconduct.